Telehealth Providers Offer Misoprostol-Only Abortions Amid Mifepristone Restrictions

Wed, 06 May 2026 00:35:00 +0200

Following a U.S. federal appeals court decision reinstating an in-person requirement for mifepristone, a key medication used in abortion care, telehealth providers swiftly adapted by offering misoprostol-only regimens. While slightly less effective than the combined mifepristone-misoprostol protocol, misoprostol alone remains a safe and legal alternative endorsed by major medical organizations, including the American College of Obstetricians and Gynecologists and the World Health Organization. Providers like Carafem, Planned Parenthood, and HeyJane have ensured continuity of care by communicating these options to patients, emphasizing that medication abortion remains accessible. The Supreme Court temporarily paused the appeals court ruling, allowing remote mifepristone access until May 11, 2026. However, ongoing legal challenges and potential new legislation, such as Senator Josh Hawley's bill banning mifepristone, underscore the uncertainty surrounding access. Despite these hurdles, r